Biosergen AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '19 Dec 31, 2019
Revenue	-	-	-	-	-	1.31
Cost of Revenue	-	-	0.46	0.28	0.21	-
Gross Profit	-	-	-0.46	-0.28	-0.21	1.31
Selling, General & Admin	32.95	20.69	34.32	38.29	50.52	-
Other Operating Expenses	-2.26	-1.49	-7.51	-4.44	-9.84	6.45
Operating Expenses	30.69	19.2	26.81	33.85	40.68	6.45
Operating Income	-30.69	-19.2	-27.27	-34.13	-40.89	-5.14
Interest Expense	-	-0.08	-0.01	-0.05	-0.29	-0.49
Interest & Investment Income	0.1	0.09	0.24	0.14	-	0.27
Other Non Operating Income (Expenses)	-	-	-	-0	-	-
Pretax Income	-30.59	-19.2	-27.04	-34.05	-41.18	-5.36
Net Income	-30.59	-19.2	-27.04	-34.05	-41.18	-5.36
Net Income to Common	-30.59	-19.2	-27.04	-34.05	-41.18	-5.36
Shares Outstanding (Basic)	3	2	1	0	0	1
Shares Outstanding (Diluted)	3	2	1	0	0	1
Shares Change (YoY)	287.06%	370.34%	63.31%	11.05%	-74.16%	-
EPS (Basic)	-8.83	-8.00	-53.00	-109.00	-146.40	-4.92
EPS (Diluted)	-8.83	-8.00	-53.00	-109.00	-146.40	-4.92
Gross Margin	-	-	-	-	-	100.00%
Operating Margin	-	-	-	-	-	-392.29%
Profit Margin	-	-	-	-	-	-409.33%
EBIT	-30.69	-19.2	-27.27	-34.13	-40.89	-5.14
Revenue as Reported	2.47	1.94	9.38	5.18	10.29	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.